news MicroRNA in red blood cells causes vascular damage in type 2 diabetes 9 November 2021 | By Anna Begley (Drug Target Review) Researchers discovered that cardiovascular damage was caused by reduced microRNA-210 levels in patient cells and mice with type 2 diabetes.
news Antibiotic-free hydrogel fights against drug-resistant bacteria 19 October 2021 | By Anna Begley (Drug Target Review) New dendritic hydrogels were tested against several infectious bacteria and could be used as an an antibiotic-free treatment in the future.
news Nanobubbles show promise for delivering anti-inflammation treatments 8 October 2021 | By Anna Begley (Drug Target Review) Nanobubbles known as extracellular vesicles (EVs) were shown to deliver protein drugs in animal models with inflammatory diseases.
news MAIT immune cells revealed as key in toxic shock development 26 November 2019 | By Victoria Rees (Drug Target Review) Researchers have found that MAIT immune cells respond rapidly to group A streptococcal infection, causing inflammation and toxic shock, which presents a therapeutic target.
news Frizzled receptors could be drug targets for treating major diseases 5 December 2018 | By Iqra Farooq (Drug Target Review) Frizzled receptors, from the GPCR family, could soon be a target to treat numerous diseases such as cancer, fibrosis and CVD...